Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Company Overview - Legend Biotech Corporation is a global leader in cell therapy with over 2,800 employees, making it the largest standalone cell therapy company [3] - The company is pioneering treatments that aim to transform cancer care, particularly through its CAR-T cell therapy [3] - CARVYKTI, a one-time treatment for relapsed or refractory multiple myeloma, is developed and marketed in collaboration with Johnson & Johnson [3] Upcoming Events - Ying Huang, Ph.D., the CEO of Legend Biotech, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 9, 2025, at 4:05 p.m. ET [1] - The live webcast of the event will be accessible through the Investor Relations section of Legend's website, with a replay available approximately 48 hours after the event [2]